rs2963154 — NR3C1

Intronic NR3C1 variant with TT genotype enriched in Polish centenarians; C allele associated with elevated cholesterol in the oldest-old

See your personal result for NR3C1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Longevity Signal in the Glucocorticoid Receptor — NR3C1 rs2963154

Your glucocorticoid receptor (GR), encoded by NR3C1, is the molecular dock through which cortisol communicates with nearly every cell in your body. It governs inflammation, metabolism, stress adaptation, immune function, and — increasingly clear from longevity research — the pace at which your cells age. Most NR3C1 variants studied to date alter how strongly the receptor responds to cortisol; rs2963154 sits in an intron of the gene, and its precise functional mechanism has not been characterized at the molecular level. What has been documented is its association with exceptional human longevity.

In a 2019 study of Polish nonagenarians and centenarians11 In a 2019 study of Polish nonagenarians and centenarians
Olczak et al. Glucocorticoid receptor (NR3C1) gene polymorphisms are associated with age and blood parameters in Polish Caucasian nonagenarians and centenarians. Exp Gerontol. 2019;116:20-24, researchers compared NR3C1 genotypes in 552 individuals aged 95–106 years against 284 cord blood samples from newborns — a design that captures allele enrichment across an entire century of human life. The TT genotype of rs2963154 was significantly more frequent in the long-lived cohort (p = 0.002), one of the strongest associations observed among the three NR3C1 variants examined. Carriers of the CC genotype showed elevated total cholesterol (p = 0.007) and HDL cholesterol (p = 0.039) — a lipid-metabolism difference that may be part of the same biological story as the longevity signal.

The Mechanism

rs2963154 is an intronic T-to-C substitution at chromosome 5 position 143,362,972 (GRCh38), within the body of the NR3C1 gene. The plus-strand alleles are T (reference, major) and C (alternate, minor). Because intronic variants do not alter the protein sequence, rs2963154 likely influences NR3C1 through regulatory effects on transcription, splicing, or mRNA processing — but these mechanisms have not been characterized in published studies. It may tag a haplotype in linkage disequilibrium with a functional regulatory element, or it may affect the relative production of the multiple NR3C1 splice isoforms (including the glucocorticoid-resistant GRβ isoform whose abundance is regulated by the nearby rs6198 variant).

What is mechanistically established is that GR activity has a direct path to lipid metabolism. A 2025 study in the Journal of Clinical Investigation22 A 2025 study in the Journal of Clinical Investigation
Durumutla et al. The human glucocorticoid receptor variant rs6190 increases blood cholesterol and promotes atherosclerosis. J Clin Invest. 2025 demonstrated that altered glucocorticoid receptor transactivation in liver cells directly upregulates PCSK9 and BHLHE40 — both negative regulators of LDL and HDL receptor expression. This establishes a direct biochemical pathway through which NR3C1 variants can modulate circulating cholesterol levels without affecting inflammatory or stress pathways. The cholesterol elevation seen in rs2963154 CC carriers fits within this GR-driven lipid biology.

The broader longevity context is the hypothalamic-pituitary-adrenal axis33 hypothalamic-pituitary-adrenal axis
The HPA axis governs cortisol secretion from the adrenal glands in response to stress, circadian rhythms, and metabolic signals — it is one of the central clocks of biological aging. Advancing age is characterized by progressive HPA dysregulation with higher cortisol exposure and impaired negative feedback. Genetic variants that fine-tune NR3C1 expression or activity could influence the trajectory of this dysregulation over decades, making them candidates for longevity association even when their acute effects on cortisol signaling are modest.

The Evidence

The primary evidence comes from a single population study with methodological strengths and limitations worth noting. The centenarian cohort of 552 Polish individuals represents exceptional statistical power for longevity genetics — reaching age 95–106 is a phenotype that fewer than 1 in 1,000 people in any population achieve, making genotype enrichment meaningful. The newborn cord blood comparison controls for birth-cohort effects by representing the ancestral allele distribution before any survival selection.

The p = 0.002 association for rs2963154 TT genotype survives correction better than the other two variants studied (rs10515522 at p = 0.016 and rs2918418 at p = 0.028), suggesting it is the primary longevity signal among the three. However, this remains a single-study finding in a specific European population. The study found no associations with inflammatory markers (CRP, white blood count), fasting glucose, diabetes, cardiovascular events, or cognitive function, suggesting the longevity mechanism is not mediated through these common aging pathways.

The cholesterol elevation in CC genotype carriers — specifically both total cholesterol (p = 0.007) and HDL (p = 0.039) — adds a metabolic dimension. Elevated HDL is often considered a longevity marker in observational data, though its relationship with actual cardiovascular protection is complex. Whether the cholesterol association is a mechanism of risk, an epiphenomenon, or a metabolically beneficial pattern in the context of extreme old age remains unclear from the available data.

This variant has not appeared in GWAS catalog studies for cardiovascular traits, lipid levels, or longevity in larger European or global cohorts, which limits cross-population validation. Given the C allele frequency of ~14.5% in Europeans, adequately powered GWAS would have been expected to detect a survival-enrichment signal if the effect were large — its absence in GWAS suggests either population-specific effect (Polish Caucasian), modest effect size, or that longevity studies of sufficient size have not yet been conducted with adequate power.

Practical Implications

The TT genotype is the ancestral common form, and its enrichment in centenarians means that TT carriers carry whatever protective architecture the locus confers. The rarer CC genotype, by contrast, was not enriched in the oldest-old — it was relatively depleted — and it specifically associates with higher cholesterol in survivors. Intermediate CT carriers fall between these poles.

Given the emerging evidence level and the lack of established mechanistic understanding, this variant does not warrant aggressive clinical interventions. Rather, it provides additional context for cholesterol monitoring in C-allele carriers and is consistent with the broader picture of NR3C1 variants influencing metabolic health through GR-driven lipid regulation.

The co-occurrence of this SNP in the same gene as the well-characterized BclI (rs41423247) and 9β (rs6198) variants offers potential for haplotype-level interpretation. Individuals carrying multiple NR3C1 variants should consider the combined context of GR sensitivity and this longevity signal.

Interactions

rs2963154 shares the NR3C1 gene with two variants already in the GeneOps database: the BclI polymorphism (rs41423247), which modulates glucocorticoid receptor sensitivity and depression/stress vulnerability, and the 9β variant (rs6198), which shifts the balance toward the glucocorticoid-resistant GRβ isoform. Haplotype analysis across these three variants has not been published, but they likely operate through partially overlapping and partially distinct mechanisms on NR3C1 expression and GR function.

The study also examined rs10515522 (another NR3C1 intronic variant) and rs2918418, which showed related but weaker longevity associations (p = 0.016 and p = 0.028 respectively). Carriers of the rs10515522 minor allele showed significantly better survival rates in the centenarian cohort — suggesting the two variants may tag related or complementary aspects of the same longevity-associated NR3C1 haplotype.

Genotype Interpretations

What each possible genotype means for this variant.

TT Longevity-Enriched Genotype Beneficial

TT genotype enriched in Polish centenarians — the most common and longevity-associated configuration

You carry two copies of the ancestral T allele, the genotype significantly enriched in individuals who survived to age 95–106 in a Polish centenarian cohort (p = 0.002 compared to newborn controls). About 73% of people of European descent share this configuration, making it the most common genotype. The TT genotype was not associated with elevated cholesterol or other metabolic disadvantages in the oldest-old population.

This association does not guarantee longevity — it reflects a genetic background that was statistically more common among exceptional survivors in one study population. The mechanism through which the TT genotype may confer advantage is not yet established, but it likely involves aspects of how this intronic variant influences NR3C1 expression or splice isoform balance over a lifetime of stress exposure.

CT Intermediate Profile Intermediate

One copy of the C allele — intermediate longevity-association profile

You carry one copy of the C allele. In the Polish centenarian cohort, the CT genotype was not as enriched in long-lived individuals as the TT genotype, representing an intermediate position between the longevity-associated TT and the metabolically distinct CC profile. About 25% of people of European descent share this heterozygous configuration.

The cholesterol elevation observed in CC carriers was not reported for CT carriers in the primary study, suggesting the lipid metabolic effect may operate in a recessive or dose-dependent manner. Your overall NR3C1 glucocorticoid receptor function is likely not substantially altered by this intronic variant alone.

CC Cholesterol-Elevated Profile High Risk

Two copies of the C allele — genotype depleted in centenarians, associated with elevated cholesterol in extreme old age

The NR3C1 glucocorticoid receptor acts as a transcriptional regulator in the liver, where it controls cholesterol metabolism genes including PCSK9 (a negative regulator of LDL receptors) and BHLHE40 (a negative regulator of HDL receptors). Research on other NR3C1 coding variants (particularly rs6190) has directly demonstrated that altered GR transactivation raises circulating cholesterol by reducing hepatic uptake of both LDL and HDL particles. The rs2963154 CC genotype's association with elevated cholesterol in centenarians is consistent with this same pathway operating through an intronic regulatory mechanism.

The depletion of CC carriers from the centenarian cohort compared to cord blood controls implies that this genotype may be associated with disadvantages over a lifetime — whether through the lipid pathway or through mechanisms not yet characterized. The CC carrier prevalence in Europeans (~2%) means the study's ability to quantify the survival disadvantage with precision was limited by sample size.

The elevated HDL in CC survivors is notable. While high HDL is often cited as cardioprotective in epidemiological studies, extremely elevated HDL has been linked to reverse cholesterol transport dysfunction in some contexts, and genetic elevations in HDL do not always confer the expected cardiovascular benefit. In the context of NR3C1-driven HDL elevation, monitoring the full lipid panel (including HDL function rather than just HDL-C levels) is warranted.